Denali Therapeutics logo

Denali Therapeutics

Denali Therapeutics Inc. is a biotechnology company that focuses on the discovery and development of therapies for patients who are suffering from neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, ALS, and more.

1

Funding Rounds

$130.0m

Money raised

Overview

Denali Therapeutics Inc. is a biotechnology company that focuses on the discovery and development of therapies for patients who are suffering from neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, ALS, and more.

Funding series

Funding Series Analysis

The company Denali Therapeutics has raised a total of $130m in funding over 1 rounds.

Key Insights:

  • Denali Therapeutics Series B round, August 2016: $130m
Denali Therapeutics logo
Denali Therapeutics Series B round, August 2016 $130m

Industries

Denali Therapeutics is active in the following industries:
  • Healthcare
  • Drug discovery
  • Therapeutics
  • Biomedical engineering
  • Biopharmaceutical
  • Technology
  • Neuroscience
  • Alzheimer's disease
  • Parkinson's disease
  • Biology
  • Biotechnology
  • Medicine
  • Neurobiology
  • Engineering
  • Synthetic chemistry
  • Neurodegenerative Disease